Biomed-Lublin signs distriubution deal with Bioton for thrombin
…in Poland of Biomed’s Distreptaza, a drug for treating inflammations of the pelvic organs in rectal suppository form. In the first three quarters of 2018, the company generated sales revenues of PLN 23.2m (€5m), marginally lower than in the same nine months of 2017.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)